Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
618.20
5.95 (0.97%)
BSENSE

Aug 25, 03:30 PM

BSE+NSE Vol: 46.58 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryLincoln Pharma. VS Pharmaceuticals & Biotechnology
 
1D
0.97%
0.48%
1W
-0.15%
0.74%
1M
6.59%
2.39%
YTD
27.74%
-6.87%
1Y
13.45%
-2.54%
3Y
28.39%
26.31%
5Y
90.1%
46.29%
10Y
191.26%
183.22%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.29%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.04%
0%
-14.04%
6 Months
0.97%
0%
0.97%
1 Year
13.45%
0.33%
13.78%
2 Years
-12.41%
0.25%
-12.16%
3 Years
28.39%
0.62%
29.01%
4 Years
119.88%
1.11%
120.99%
5 Years
90.1%
1.25%
91.35%

Latest dividend: 1.8 per share ex-dividend date: Sep-12-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
-1.8%
4
Quartile
quartile-4
Mar-Jun
10.36%
1
Quartile
quartile-1
Dec-Mar
16.74%
2
Quartile
quartile-2
YTD
12.36%
4
Quartile
quartile-4
2025
-38.57%
3
Quartile
quartile-3
2024
29.25%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-1.8%
4
Quartile
quartile-4
Mar-Jun
10.36%
1
Quartile
quartile-1
Dec-Mar
16.74%
2
Quartile
quartile-2
YTD
12.36%
4
Quartile
quartile-4
2025
-38.57%
3
Quartile
quartile-3
2024
29.25%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Lincoln Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-1.8%
4
Quartile
quartile-4
Mar-Jun
10.36%
1
Quartile
quartile-1
Dec-Mar
16.74%
2
Quartile
quartile-2
YTD
12.36%
3
Quartile
quartile-3
2025
-38.57%
2
Quartile
quartile-2
2024
29.25%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available